BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21471284)

  • 1. Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel.
    Ganguly A; Yang H; Cabral F
    Mol Cancer Ther; 2011 Jun; 10(6):929-37. PubMed ID: 21471284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemid.
    Yin S; Cabral F; Veeraraghavan S
    Mol Cancer Ther; 2007 Oct; 6(10):2798-806. PubMed ID: 17938271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance.
    Ganguly A; Yang H; Pedroza M; Bhattacharya R; Cabral F
    J Biol Chem; 2011 Oct; 286(42):36378-84. PubMed ID: 21903575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mutations that confer paclitaxel resistance.
    Yin S; Bhattacharya R; Cabral F
    Mol Cancer Ther; 2010 Feb; 9(2):327-35. PubMed ID: 20103599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of microtubule detachment from centrosomes and spindle poles.
    Ganguly A; Yang H; Cabral F
    Methods Cell Biol; 2013; 115():49-62. PubMed ID: 23973065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel resistance in cells with reduced beta-tubulin.
    Wang Y; Cabral F
    Biochim Biophys Acta; 2005 Jun; 1744(2):245-55. PubMed ID: 15950754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
    Hari M; Yang H; Zeng C; Canizales M; Cabral F
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell division.
    Yang H; Ganguly A; Yin S; Cabral F
    Cytoskeleton (Hoboken); 2011 Mar; 68(3):175-87. PubMed ID: 21309084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
    Hari M; Wang Y; Veeraraghavan S; Cabral F
    Mol Cancer Ther; 2003 Jul; 2(7):597-605. PubMed ID: 12883031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.
    Bhattacharya R; Cabral F
    J Biol Chem; 2009 May; 284(19):13023-32. PubMed ID: 19282281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
    Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminus of mitotic centromere-associated kinesin (MCAK) inhibits its lattice-stimulated ATPase activity.
    Moore A; Wordeman L
    Biochem J; 2004 Oct; 383(Pt 2):227-35. PubMed ID: 15250824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
    Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
    Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.
    Sanhaji M; Friel CT; Wordeman L; Louwen F; Yuan J
    Oncotarget; 2011 Dec; 2(12):935-47. PubMed ID: 22249213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.
    Wang Y; Veeraraghavan S; Cabral F
    Biochemistry; 2004 Jul; 43(28):8965-73. PubMed ID: 15248754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.
    Yang H; Cabral F
    J Biol Chem; 2007 Sep; 282(37):27058-27066. PubMed ID: 17627938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-dependent cell lines reveal a novel drug activity.
    Ganguly A; Yang H; Cabral F
    Mol Cancer Ther; 2010 Nov; 9(11):2914-23. PubMed ID: 20978163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel.
    Blade K; Menick DR; Cabral F
    J Cell Sci; 1999 Jul; 112 ( Pt 13)():2213-21. PubMed ID: 10362551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCAK and paclitaxel have differential effects on spindle microtubule organization and dynamics.
    Rizk RS; Bohannon KP; Wetzel LA; Powers J; Shaw SL; Walczak CE
    Mol Biol Cell; 2009 Mar; 20(6):1639-51. PubMed ID: 19158381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization.
    Pakala SB; Nair VS; Reddy SD; Kumar R
    J Biol Chem; 2012 Nov; 287(48):40560-9. PubMed ID: 23055517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.